Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Ricketts CJ, Crooks DR, Sourbier C, et al. SnapShot: renal cell carcinoma. Cancer Cell. 2016;29(4):610–610.e1.
   PubMed Web of Science ®Google Scholar
• Choueiri TK, Motzer RJ, Longo DL. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354–366.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(6):804–834.
   Google Scholar
• Kang HW,Kim SM, Kim WT, et al. The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma. J Cancer Res Clin Oncol. 2019;146(1):187–196.
   PubMed Web of Science ®Google Scholar
• Frye M, Blanco S. Post-transcriptional modifications in development and stem cells. Development. 2016;143(21):3871–3881.
   PubMed Web of Science ®Google Scholar
• Ma P, Pan Y, Li W, et al. Extracellular vesicles-mediated noncoding RNAs transfer in cancer. J Hematol Oncol. 2017;10(1):57.
   PubMedGoogle Scholar
• Sun F, Wu K, Yao Z, et al. Long noncoding RNA PVT1 promotes prostate cancer metastasis by increasing NOP2 expression via targeting tumor suppressor MicroRNAs. Onco Targets Ther. 2020;13:6755–6765.
   PubMed Web of Science ®Google Scholar
• Sun F, Wu K, Yao Z, et al. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer. Aging (Albany NY). 2020;12(12):11500–11516.
   PubMedGoogle Scholar
• Gong Y, Liu Y, Wang T, et al. Age-associated proteomic signatures and potential clinically actionable targets of colorectal cancer. Mol Cell Proteomics. 2021;20:100115.
   PubMed Web of Science ®Google Scholar
• Luo Y, Shen D, Chen L, et al. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Aging (Albany NY). 2019;11(16):6029–6052.
   PubMedGoogle Scholar
• Wang Y, Zheng B, Xu M, et al. Prediction and analysis of hub genes in renal cell carcinoma based on CFS gene selection method combined with Adaboost algorithm. Med Chem. 2019;16(5):654–663.
   Web of Science ®Google Scholar
• Zuo Y, Zhang L, Tang W, et al. Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma. J Cell Mol Med. 2019;23(11):7762–7772.
   Web of Science ®Google Scholar
• Zeng JH, Lu W, Liang L, et al. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. J Transl Med. 2019;17(1):281.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu F, Cheng W, et al. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer. Exp Cell Res. 2020;395(2):112235.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
   PubMed Web of Science ®Google Scholar
• Chen F, Chandrashekar DS, Varambally S, et al. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10(1):5679.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269): pl1.
   Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database):D561–8.
   PubMed Web of Science ®Google Scholar
• Miao Y, Wang J, Li Q, et al. Prognostic value and immunological role of PDCD1 gene in pan-cancer. Int Immunopharmacol. 2020;89(Pt B):107080.
   PubMedGoogle Scholar
• Hundal J, Carreno BM, Petti AA, et al. pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 2016;8(1):11.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang Y, Miao C, et al. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity. Cancer Cell Int. 2021;21(1):140.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cong R, Liu S, et al. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma. Cancer Cell Int. 2021;21(1):46.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
   PubMed Web of Science ®Google Scholar
• Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 2009;9(7):489–499.
   PubMed Web of Science ®Google Scholar
• Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer. 2016;16(8):525–537.
   PubMed Web of Science ®Google Scholar
• Ji C, Wang Y, Wang Y, et al. Immune-related genes play an important role in the prognosis of patients with testicular germ cell tumor. Ann Transl Med. 2020;8(14):866.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Mo S, Dai W, et al. Development and validation of an autophagy score signature for the prediction of post-operative survival in colorectal cancer. Front Oncol. 2019;9:878.
   PubMed Web of Science ®Google Scholar
• Wu M, Li X, Zhang T, et al. Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer. Front Oncol. 2019;9:996.
   PubMed Web of Science ®Google Scholar
• Xing Q, Liu S, Jiang S, et al. Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA). Transl Androl Urol. 2020;9(5):2054–2070.
   PubMed Web of Science ®Google Scholar
• Schwaederle M, Zhao M, Lee JJ, et al. Impact of precision medicine in diverse cancers: a meta-analysis of Phase II clinical trials. J Clin Oncol. 2015;33(32):3817–3825.
   PubMed Web of Science ®Google Scholar
• Coppin C, Kollmannsberger C, Le L, et al. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011;108(10):1556–1563.
   PubMed Web of Science ®Google Scholar
• Motolani A, Martin M, Sun M, et al. Phosphorylation of the regulators, a complex facet of NF-κB signaling in cancer. Biomolecules. 2020;11(1):15.
   PubMed Web of Science ®Google Scholar
• Taddei ML, Pardella E, Pranzini E, et al. Role of tyrosine phosphorylation in modulating cancer cell metabolism. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188442.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhong W, Cao R. Phosphorylation of the mRNA cap-binding protein eIF4E and cancer. Cell Signal. 2020;73:109689.
   PubMed Web of Science ®Google Scholar
• Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ. 2021;28(5):1548–1562.
   PubMed Web of Science ®Google Scholar
• Ma S, Zhou B, Yang Q, et al. A transcriptional regulatory loop of master regulator transcription factors, PPARG, and fatty acid synthesis promotes esophageal adenocarcinoma. Cancer Res. 2021;81(5):1216–1229.
   PubMed Web of Science ®Google Scholar
• Guo Y, Song J, Wang Y, et al. Concurrent genetic alterations and other biomarkers predict treatment efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer: a review. Front Oncol. 2020;10:610923.
   PubMed Web of Science ®Google Scholar
• Hsu LW, Huang KH, Chen MH, et al. Genetic alterations in gastric cancer patients according to sex. Aging (Albany NY). 2020;13(1):376–388.
   PubMedGoogle Scholar
• Rizzo A, Ricci AD, Brandi G. Recent advances of immunotherapy for biliary tract cancer. Expert Rev Gastroenterol Hepatol. 2021;1–10. DOI:10.1080/17474124.2021.1948328
   Web of Science ®Google Scholar
• Zeng D, Ye Z, Wu J, et al. Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer. Theranostics. 2020;10(15):7002–7014.
   PubMed Web of Science ®Google Scholar
• Cho J-K, Lee G-J, Yi K-I, et al. Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients. Eur J Cancer. 2015;51(10):1303–1311.
   PubMed Web of Science ®Google Scholar
• Li J, Liu Y, Yan Z, et al. A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy. Br J Cancer. 2014;110(5):1110–1117.
   PubMed Web of Science ®Google Scholar
• Xing Q, Ji C, Zhu B, et al. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Cancer Med. 2020;9(19):7034–7051.
   PubMed Web of Science ®Google Scholar
• Pan Q, Wang L, Chai S, et al. The immune infiltration in clear cell renal cell carcinoma and their clinical implications: a study based on TCGA and GEO databases. J Cancer. 2020;11(11):3207–3215.
   PubMed Web of Science ®Google Scholar
• Şenbabaoğlu Y, Gejman RS, Winer AG, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17(1):231.
   PubMed Web of Science ®Google Scholar
• Chen YN, Hou SQ, Jiang R, et al. EZH2 is a potential prognostic predictor of glioma. J Cell Mol Med. 2020; 25(2):925–936.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen Z, Zhao P, et al. Prognostic and immune regulating roles of YIF1B in pan-cancer: a potential target for both survival and therapy response evaluation. Biosci Rep. 2020; 40(7). DOI:10.1042/BSR20201384
   Google Scholar